Vitamin D-dependent rickets type II is a rare hereditary disease that
results from target organ resistance to the action of 1,25-dihydroxyvi
tamin D-3. There is a great heterogeneity in the clinical presentation
of this condition. The affected patients usually present early in chi
ldhood with clinical and biochemical evidence of rickets. Physiologica
l replacement dosage of 1,25-dihydroxyvitamin D-3 has no therapeutic e
ffect. Responses to pharmacological doses of vitamin D metabolites or
long-term calcium infusion have been variable. A case is reported here
of an 8 year old girl, of consanguineous parents with vitamin D-depen
dent rickets, type II, in whom treatment with high dose oral calcium r
esulted in marked biochemical and radiological improvement. It is conc
luded that high dose oral calcium treatment is an effective treatment
option for patients with vitamin D-dependent rickets type II.